Aprea Therapeutics, Inc. APRE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

55/100

3/7 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

共有 50 笔近期内部人交易记录记录，涉及 Aprea Therapeutics, Inc. (APRE), 包括 47 笔买入 和 2 笔卖出. 内部人买入总额为 $933.51K 内部人卖出总额为 $47.13K.

近期活跃的重要内部人包括 Peters Richard, Hamill John P., Gilad Oren. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — APRE

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2026-03-31	Peters Richard	Director	知情买入	123,915	$0.68	$84.63K	123,915
2026-03-31	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	知情买入	30,978	$0.68	$21.16K	30,978
2026-03-12	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	限制性股票授予 (RSU)	40,380	$0.77	$30.89K	40,380
2026-03-12	Gilad Oren	President/ceo	限制性股票授予 (RSU)	80,700	$0.77	$61.74K	80,700
2026-01-30	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	知情买入	5,700	$0.77	$4.36K	5,700
2026-01-30	Gilad Oren	President/ceo	知情买入	28,100	$0.77	$21.5K	28,100
2025-12-10	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	知情买入	5,000	$1.04	$5.2K	5,000
2025-12-10	Duey Marc	Director	知情买入	21,459	$1.04	$22.32K	21,459
2025-12-10	Gilad Oren	President/ceo	知情买入	21,459	$0.00	$2.15	21,459
2025-06-05	Henneman John B Iii	Director	限制性股票授予 (RSU)	4,185	$1.81	$7.57K	4,185
2025-06-05	Bizzari Jean-pierre	Director	限制性股票授予 (RSU)	1,045	-	-	1,045
2025-06-05	Peters Richard	Director	限制性股票授予 (RSU)	1,045	-	-	3,119
2025-06-05	Grissinger Michael	Director	限制性股票授予 (RSU)	1,045	-	-	2,889
2025-06-05	Seizinger Bernd R.	Director	限制性股票授予 (RSU)	4,185	$1.81	$7.57K	4,185
2025-06-05	Gruia Gabriela	Director	限制性股票授予 (RSU)	1,045	-	-	1,045
2025-06-05	Duey Marc	Director	限制性股票授予 (RSU)	4,185	$1.81	$7.57K	4,185
2025-06-05	Pamukcu Rifat	Director	限制性股票授予 (RSU)	4,185	$1.81	$7.57K	4,185
2025-04-03	Gilad Oren	President/ceo	知情买入	3,003	$1.87	$5.62K	343,123
2025-03-27	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	限制性股票授予 (RSU)	13,460	$2.20	$29.61K	13,460
2025-03-27	Gilad Oren	President/ceo	限制性股票授予 (RSU)	26,900	$2.20	$59.18K	26,900
2024-10-23	Gilad Oren	President/ceo	知情买入	500	$3.92	$1.96K	333,395
2024-10-18	Duey Marc	Director	知情卖出	6,462	$4.58	$29.58K	233,651
2024-10-16	Duey Marc	Director	知情买入	30,000	$4.39	$131.7K	240,113
2024-10-15	Gilad Oren	President/ceo	知情买入	250	$2.90	$725.00	332,895
2024-10-14	Gilad Oren	President/ceo	知情买入	1,000	$2.59	$2.59K	332,645
2024-10-14	Duey Marc	Director	知情买入	190	$2.58	$490.20	210,113
2024-10-11	Seizinger Bernd R.	Director	知情买入	10,000	$2.68	$26.8K	44,730
2024-10-11	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	知情买入	50	$2.46	$123.19	19,368
2024-10-10	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	知情买入	450	$2.61	$1.17K	19,318
2024-10-10	Gilad Oren	President/ceo	知情买入	150	$2.54	$381.00	331,645
2024-06-20	Henneman John B Iii	Director	限制性股票授予 (RSU)	4,185	$4.07	$17.03K	4,185
2024-06-20	Peters Richard	Director	限制性股票授予 (RSU)	1,045	-	-	2,074
2024-06-20	Grissinger Michael	Director	限制性股票授予 (RSU)	1,045	-	-	1,844
2024-06-20	Seizinger Bernd R.	Director	限制性股票授予 (RSU)	4,185	$4.07	$17.03K	4,185
2024-06-20	Duey Marc	Director	限制性股票授予 (RSU)	4,185	$4.07	$17.03K	4,185
2024-06-20	Pamukcu Rifat	Director	限制性股票授予 (RSU)	4,185	$4.07	$17.03K	4,185
2024-05-01	Mirza Nadeem Q.	Chief Medical Officer	处置	2,250	$7.80	$17.55K	-
2024-05-01	Mirza Nadeem Q.	Chief Medical Officer	限制性股票授予 (RSU)	6,730	-	-	6,730
2024-03-28	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	限制性股票授予 (RSU)	13,460	$6.69	$90.05K	13,460
2024-03-28	Gilad Oren	President, CEO	限制性股票授予 (RSU)	26,900	$6.69	$179.96K	26,900
2024-03-13	Henneman John B Iii	Director	知情买入	3,430	-	-	3,430
2024-03-13	Hamill John P.	Srvp/cfo/prin Fin & Acct Ofcr	知情买入	505	-	-	505
2024-03-13	Seizinger Bernd R.	Director	知情买入	3,430	-	-	3,430
2024-03-13	Gilad Oren	President, CEO	知情买入	1,000	-	-	1,000
2023-08-23	Henneman John B Iii	Director	限制性股票授予 (RSU)	500	-	-	1,279
2023-08-23	Bizzari Jean-pierre	Director	未知	-	-	-	-
2023-08-23	Bizzari Jean-pierre	Director	限制性股票授予 (RSU)	12,500	$3.65	$45.63K	12,500
2023-08-23	Peters Richard	Director	限制性股票授予 (RSU)	500	-	-	1,029
2023-08-23	Grissinger Michael	Director	限制性股票授予 (RSU)	500	-	-	799
2023-08-23	Seizinger Bernd R.	Director	限制性股票授予 (RSU)	2,000	$3.65	$7.3K	2,000